series-c-plus
Stage
1
Investors
About
F-star is a clinical-stage company focused on developing bispecific antibody therapeutics, including a lead program targeting LAG-3 and PD-L1.
Explore F-star's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.